Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
284
result was found. Results that relate to
Drug
Clinical characteristics and drug resistance analysis of 408 patients with Escherichia coli bloodstream infection
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(5):507-514.
11979 times
2803 times
HU Peng
CAI Tongjian
WANG Yi
CHENG Yao
LIU Qiuqian
XIAO Hong
Bloodstream infection
Escherichia coli
Extended-spectrum β-lactamases
Clinical features
Drug
resistance
Details
Signal mining and analysis of adverse events of basiliximab used in solid organ transplantation based on FAERS database
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(5):515-523.
11708 times
2962 times
CHENG Saisai
ZHU Feng
ZHOU Bi
Basiliximab
Solid organ transplantation
Adverse
drug
event
FAERS database
Data mining
Details
Evaluation of off-label use of flupentixol melitracen based on evidence-based medicine
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(5):539-547.
10946 times
3116 times
WANG Chuanquan
CAO Di
ZHANG Shiyang
Flupentixol melitracen
Evidence-based medicine
Gastritis
Vertigo
Off-label
drug
use
Details
The research progress of siRNA drugs in obesity
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(5):589-594.
11614 times
2991 times
JIANG Fengxuan
LU Qingmiao
LU Yibing
siRNA
drug
s
Obesity
Weight loss
Delivery system
Details
Pharmaceutical care of a child with high-risk neuroblastoma using naxitamab
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(5):595-599.
9613 times
2567 times
CHEN Yin
LIU Xin
YU Liting
ZHANG Min
Neuroblastoma
Naxitamab
Adverse
drug
reaction
Pharmaceutical care
Pain
Details
Analysis of a case of 5-hydroxytryptamine syndrome caused by oxycodone hydrochloride sustained-release tablets
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(6):715-719.
9029 times
2881 times
ZHANG Mengyu
XING Xiaomin
WANG Jikai
LI Jinfeng
ZHANG Yuan
JING Fanbo
Oxycodone hydrochloride sustained-release tablets
5-Hydroxytryptamine Syndrome
Morphine sulfate sustained-release tablets
Adverse
drug
reaction
Details
Feasibility study on mercury-free green testing of hydrochloride salt drugs in the Chinese Pharmacopoeia
Published on
Frontiers in Pharmaceutical Sciences
2025,29(5):756-763.
5257 times
769 times
LIU Huiying
LI Shangying
HUANG Hai
XU Wankui
Hydrochloride
drug
s
Method substitution
Mercury salt elimination
Green
drug
testing
Quality control
Details
Research progress of antibody-drug conjugates and analysis of their current application status in gastric cancer patients
Published on
Frontiers in Pharmaceutical Sciences
2025,29(5):877-886.
5246 times
747 times
ZHU Wenbing
GUO Chao
DAI Yujie
QIN Yue
ZHOU Jiangping
ZHU Wenjing
Antibody-
drug
conjugates
Targeted therapy
Gastric cancer patients
Research progress
Application Status
Details
Advances in pharmacists’ prescription management: intervention and analysis in antimicrobial use
Published on
Frontiers in Pharmaceutical Sciences
2025,29(5):887-893.
5246 times
796 times
WANG Weijuan
GU Lijia
ZHU Yanyan
GAO Hongrui
Pharmacist intervention
Antimicrobial management
Prescription review
Intelligent alert system
Rational
drug
use
Details
Severe acute liver injury induced by tolvaptan: a case report
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(7):830-834.
5873 times
799 times
WANG Kexin
SHI Erxia
ZHOU Zhongyan
HE Xuan
Tolvaptan tablets
Acute liver function injury
Adverse
drug
reactions
Details
Risk factors for multidrug-resistant gram-negative bacilli infection in patients with cerebral hemorrhage in the department of neurosurgery
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(6):632-639.
5480 times
826 times
YUAN Kang
LI Maokun
Cerebral haemorrhage
Multi
drug
resistance
Gram-negative bacilli
Risk factors
Details
Signal mining and analysis of drug-related hepatitis B virus reactivation based on FAERS database
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(6):640-649.
5603 times
795 times
CUI Zhentao
CHENG Juan
Adverse
drug
event
FAERS database
Hepatitis B virus reactivation
Signal mining
Pharmacovigilance
Details
Signals mining and analysis of adverse drug events of anifrolumab based on FAERS database
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(6):650-656.
5568 times
829 times
YAN Fanbin
WANG Jia
XU Lujie
LIU Chang
Anifrolumab
Adverse
drug
events
Signal mining
Ratio imbalance method
Pharmacovigilance
Details
Progress of real-world research of the generic and innovator drugs under the national centralized drug procurement policy
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(6):690-701.
8677 times
1105 times
ZHANG Bin
LIU Minna
LI Xiaolin
LI Jinhu
LIU Tianlong
National centralized
drug
procurement
Real world study
Clinical evaluation
Generic
drug
s
Innovator
drug
s
Effectiveness
Safety
Details
Pharmaceutical practice in the treatment of one case of ventilator-associated pneumonia caused by extensively drug-resistant Klebsiella pneumoniae
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(6):708-714.
7403 times
831 times
YUAN Minglu
ZENG Wei
WANG Genzhu
WANG Xiaoying
LI Zhongdong
Extensively
drug
resistant Klebsiella pneumoniae
Ventilator-associated pneumonia
Anti-infective treatment
Ceftazidime avibactam
Colistin sulfate
Pharmaceutical care
Details
上一页
1
2
10
11
12
13
14
15
16
17
18
19
下一页